Two Sigma Securities’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Two Sigma Securities’s Portfolio STAB Stock Details STAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-81,303	Closed	-$6.6K	–	3506
2022 Q4	$6.6K	Sell	81,303 -17,335	-18%	-$2.2K	﹤0.01%	2425
2022 Q3	$13K	Buy	98,638 +87,150	+759%	+$18.4K	﹤0.01%	2371
2022 Q2	$3K	Sell	11,488 -66,701	-85%	-$17.2K	﹤0.01%	2132
2022 Q1	$25K	Buy	+78,189	New	+$83.6K	﹤0.01%	1952
2017 Q3	–	Sell	-10,495	Closed	-$31K	–	1291
2017 Q2	$31K	Buy	+10,495	New	+$34.3K	0.01%	755

Other funds holding STAB

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

TAM

Tucker Asset Management Littleton, Colorado $343M AUM 17.55% 1-Year Est. Return

Two Sigma Securities's STAB Position: Q1 2023 in Review

Two Sigma Securities sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q1 2023, closing a stake of 81,303 shares — an estimated $6.6K sold.

Two Sigma Securities first reported a position in STAB in Q2 2017 and held it in 5 quarters. The position peaked at $31K in Q2 2017. 4 funds tracked by Wall St. Rank hold STAB as of Q1 2023.

Two Sigma Securities reported no remaining Statera Biopharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Two Sigma Securities sold 81,303 Statera Biopharma, Inc. Common Stock shares in Q1 2023, an estimated $6.6K.
Two Sigma Securities first reported a position in Statera Biopharma, Inc. Common Stock in Q2 2017 and held it in 5 quarters.
Two Sigma Securities's Statera Biopharma, Inc. Common Stock position peaked at $31K in Q2 2017.
4 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q1 2023.

Based on Two Sigma Securities's 13F filing for Q1 2023, filed 15 May 2023.